Pharmaceutical compositions comprising amlodipine maleate

Details Pharmaceutical compositions comprising amlodipine maleate Pharmaceutical compositions comprising amlodipine maleate

2005-07-19

2005-07-19

King, Gary L. (Department: 1616)

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

C451S452000, C451S464000, C451S465000, C451S489000, C514S350000, C514S355000, C514S356000, C546S321000

Reexamination Certificate

active

06919087

ABSTRACT:
An amlodipine maleate pharmaceutical composition is provided with good stability when formulated with a pH within the range of 5.5 to 7, when measured as a 20 wt % aqueous slurry. The stability can also be aided by making the pharmaceutical composition from amlodipine maleate particles having an average particle size of greater than 20 microns, preferably greater than 100 microns.

REFERENCES:
patent: 4572909 (1986-02-01), Campbell et al.
patent: 4590195 (1986-05-01), Alker et al.
patent: 4687662 (1987-08-01), Schobel
patent: 4879303 (1989-11-01), Davison et al.
patent: 4983740 (1991-01-01), Peglion et al.
patent: 5155120 (1992-10-01), Lazar et al.
patent: 5389654 (1995-02-01), Furlan et al.
patent: 5438145 (1995-08-01), Furlan et al.
patent: 5585115 (1996-12-01), Sherwood et al.
patent: 6046337 (2000-04-01), Bozsing et al.
patent: 6057344 (2000-05-01), Young
patent: 6471946 (2002-10-01), Takatsuka et al.
patent: 0 089 167 (1986-10-01), None
patent: 0 244 944 (1990-01-01), None
patent: 0 290 211 (1991-09-01), None
patent: 0 534 520 (1997-03-01), None
patent: 0 902 016 (1999-03-01), None
patent: 0 963 980 (1999-12-01), None
patent: WO 95/34299 (1995-12-01), None
patent: WO 98/26765 (1998-06-01), None
patent: 99/25688 (1999-05-01), None
patent: 99/52873 (1999-10-01), None
patent: 00/24714 (2000-05-01), None
patent: 00/35873 (2000-06-01), None
patent: 00/35910 (2000-06-01), None
Colowick and Kaplan. Methods in Enzymology Volume !, Academic Press Inc. 1995, p. 143.
Nahata et al., “Stability of enalapril maleate in three . . . ”, Am J Health-Syst Pharm vol. 55, Jun. 1998, pp 1155-1157.
Rompp Chemie Lexikon, 9th Ed. 1991, p 2771.
Nahata et al., J Am Pharm Assoc., vol. 39, No. 3, May/Jun. 1999, pp 375-377.
Alker et al., “Long-acting dihydropyridine calcium antagonists. 9. Structure activity relationships around amlodipine”, Eur J Med Chem (1991) 26, 907-913.
Amlodipine Besylate Monograph, Pharmeuropa vol. 10, No. 2, 197-198, Jun. 1998.
Faulkner et al, “Absorption of Amlodipine Unaffected by Food”, Arzneim Forsch/Drug Res. 39(11), No. 7, (1989).
McDaid and Deasy, “Formulation development of a transdermal drug delivery system for amlodipine base”, International Journal of Pharmaceutics 133 (1996) 71-83.
Arrowsmith et al., “Long-Acting Dihydropyridine Calcium Antagonists. 1. 2-Alkoxymethyl Derivatives Incorporating Basic Substituents”, J. Med. Chem. American Chemical Society, 1986, 29, 1696-1702.
FDA FOIA Material on Amlodipine Besylate, NDA No. 19-787, “Review of an Original NDA”, Oct. 10, 1990.

Affiliated with

Also associated with

Rating

Pharmaceutical compositions comprising amlodipine maleate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions comprising amlodipine maleate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions comprising amlodipine maleate will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3414938